http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_281f688065a91877436bd96cd463dcf2
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Tough |
| name | David F. Tough David F Tough |
| given-name | David F David F. |
| organization-name | †Edward Jenner Institute for Vaccine Research, Compton, Newbury, United Kingdom Adaptive Immunity Research Unit, GlaxoSmithKline Medicines Research Centre, Stevenage, SG1 2NY, United Kingdom *The Edward Jenner Institute for Vaccine Research, Compton, United Kingdom; *The Edward Jenner Institute for Vaccine Research, University of Oxford, Compton, United Kingdom; D. F. Tough and J. Sprent, Department of Immunology, IMM4, Scripps Research Institute, 10666 North Torrey Pines Road, La Jolla, California 92037, USA. Epigenetics DPU, Immuno-Inflammation Therapy Area Unit, GlaxoSmithKline, Medicines Research Centre, Stevenage SG1 2NY, UK The Edward Jenner Institute for Vaccine Research Compton Berkshire UK Department of Immunology,2 The Scripps Research Institute, La Jolla, California 92037, and *The Edward Jenner Institute for Vaccine Research, Berkshire, United Kingdom; From the Department of Immunology, IMM4, The Scripps Research Institute, La Jolla, California 92037 Epinova DPU, Immuno-Inflammation Therapeutic Area and QSCi Computational Biology, GlaxoSmithKline, Stevenage SG1 2NY, United Kingdom; and The Edward Jenner Institute for Vaccine Research, Compton, Newbury, United Kingdom 2Edward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire RG20 7NN, UK Department of Immunology, IMM4, The Scripps Research Institute, La Jolla, California, USA From the Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia; and the Edward Jenner Institute for Vaccine Research, Berkshire, United Kingdom. Department of Immunology, IMM4, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. *The Edward Jenner Institute for Vaccine Research, University of Oxford, Compton RG20 7NN, United Kingdom; Epinova Discovery Performance Unit, Immuno‐inflammation Therapeutic Area, GlaxoSmithKline, Medicines Discovery Centre Stevenage UK From the Department of Cellular and Molecular Medicine–Infectious Diseases, St George's Hospital Medical School, Cranmer Terrace, London, United Kingdom; Edward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire, United Kingdom; Department of Immunology, Wright-Fleming Institute, Imperial College, London, United Kingdom. Epigenetics DPU, Immuno-Inflammation and Oncology Therapy Area, GlaxoSmithKline, Medicines Research Centre, Stevenage SG1 2NY, United Kingdom Immunology Research Unit, GSK, Medicines Research Centre , Stevenage, Hertfordshire , UK Edward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire RG20 7NN, United Kingdom; The Scripps Research Institute La Jolla California †Edward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire, United Kingdom Immuno‐Inflammation Therapy Area GlaxoSmithKline R&D Medicines Research Centre Epinova DPU Stevenage UK Epinova Drug Performance Unit, Immuno-Inflammation Therapeutic Area and Quantitative Sciences Computational Biology, GlaxoSmithKline, Stevenage, United Kingdom; and *Edward Jenner Institute for Vaccine Research, Compton, United Kingdom; and *Edward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire, United Kingdom; and *The Edward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire, United Kingdom; and Epinova Discovery Performance Unit, Immuno-inflammation Therapeutic Area, GlaxoSmithKline, Medicines Discovery Centre, SG1 2NY, Stevenage, UK. Edward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire, United Kingdom †The Edward Jenner Institute for Vaccine Research, Compton, United Kingdom From the Edward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire, United Kingdom; Laboratory of Virology, Istituto Superiore di Sanità, Rome, Italy; and INSERM U255–Institut Curie, Paris, France. †The Edward Jenner Institute for Vaccine Research, Compton, Newbury, United Kingdom Research & Development GlaxoSmithKline Stevenage Hertfordshire UK From the *Department of Immunology, IMM4, The Scripps Research Institute, La Jolla, California 92037; ‡The R.W. Johnson Pharmaceutical Research Institute, San Diego, California 92121; and §The Edward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire, RG20 7NN, United Kingdom From the Department of Immunology, The Scripps Research Institute, La Jolla, California 92037 |
Incoming Links
Total number of triples: 138.